Which class of antibiotics is effective against typical and atypical pathogens in CAP, particularly for healthy outpatients?

• A. Beta-lactam monotherapy
• B. Macrolide or doxycycline
• C. Aminoglycoside
• D. Antifungal therapy

Answer: (B)

In CAP for healthy outpatients, the antibiotic class that best covers both typical bacteria (like Streptococcus pneumoniae) and atypical pathogens (such as Mycoplasma pneumoniae and Chlamydophila pneumoniae) is a macrolide, with doxycycline as a strong alternative. Macrolides work by inhibiting bacterial protein synthesis and have reliable activity against both groups, making them a common first-line choice for outpatient CAP when atypicals are a consideration. Doxycycline also provides good activity against typical organisms and is notably effective against atypicals, offering another convenient oral option, especially for patients who cannot take macrolides or have resistance concerns.

Beta-lactam monotherapy targets typical bacteria well but lacks reliable coverage of atypical pathogens, which is why it isn’t the best standalone choice when outpatient CAP could involve atypicals. Aminoglycosides have limited role in CAP and do not cover atypicals effectively, and antifungal therapy is not indicated for typical bacterial CAP in healthy outpatients.